Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 13.58 0.00%
AVTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $728.30M
- EPS (TTM)
- -$4.31
- Dividend yield
- None
- 52-week range
- 12.51 – 24.27
- Day range
- 13.30 – 13.96
- Volume / Avg
- 718.22K / 935.17K
- Beta
- —
- Shares outstanding
- 53.63M
- Next earnings
- Nov 5, 2026
52-week range
AVTX stock today
Avalo Therapeutics (AVTX) closed at $13.58 on Oct 7, down 0.07% (-$0.01), versus the S&P 500's 0.22% decline. Shares are 44.0% below their 52-week high of $24.27, set on May 7, 2026 and 8.6% above the 52-week low of $12.51, near the bottom of the past year's range. AVTX is down 25.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 0.7%.
Avalo Therapeutics has posted a net loss over the last twelve months (EPS of -$4.31), so its P/E ratio is not meaningful. Avalo Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Avalo Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.63
Avalo Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DSGNDesign Therapeutics Inc. | 11.69 | -2.34% | $731.58M | vs AVTX |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs AVTX |
| GYREGyre Therapeutics Inc. | 7.04 | -0.56% | $746.48M | vs AVTX |
| VSTMVerastem Inc. | 8.27 | +6.65% | $748.51M | vs AVTX |
| APMDApnimed Inc. | 18.04 | -3.27% | $751.02M | vs AVTX |
| WVEWave Life Sciences Inc. | 3.54 | +0.57% | $697.55M | vs AVTX |
| ANNXAnnexon Inc. | 4.01 | -0.50% | $760.21M | vs AVTX |
| OLMAOlema Pharmaceuticals Inc. | 7.94 | +0.25% | $694.73M | vs AVTX |
Indexes, lists and sector
Largest Health Care stocks
Avalo Therapeutics stock FAQ
What is Avalo Therapeutics's stock price today?
AVTX last traded at $13.58 as of Oct 7, 4:00 PM EDT, down 0.07% on the day. Prices are delayed at least 15 minutes.
Does Avalo Therapeutics pay a dividend?
No. Avalo Therapeutics does not currently pay a regular cash dividend.
When is Avalo Therapeutics's next earnings date?
Avalo Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.63.
Has AVTX ever split its stock?
Yes. The most recent AVTX stock split was a 1-for-240 split on Dec 29, 2023, one of 2 splits on record.
What is the AVTX 52-week high?
The 52-week high for AVTX is $24.27 and the 52-week low is $12.51. The stock is currently 44.0% below its high.